Latest Gynecologic Oncology Group Stories
A new approach to treating advanced ovarian cancer may significantly improve patients’ survival compared to standard chemotherapy regimens, according to results published online today as the
SEATTLE, Feb. 3, 2015 /PRNewswire/ -- CTI BioPharma Corp.
- Management Team, Funding, Immunotherapy Trials - SEATTLE, Sept.
LONDON, June 2, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Company also announces designation of Orphan Drug Status by FDA for VTX-2337 in Ovarian Cancer SEATTLE, April 17, 2014 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc.
SEATTLE, Jan. 28, 2014 /PRNewswire/ -- Cell Therapeutics, Inc.
The affiliation allows further collaboration to advance cancer research. Fort Myers, FL and Scottsdale, AZ (PRWEB) August 20, 2013 21st Century Oncology
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.